Minimizing misdiagnosis: Psychometric criteria for possible or probable memory impairment

Dementia and Geriatric Cognitive Disorders

Volumn 27, Issue 5, 2009, Pages 439-450

  Brooks, Brian L ^a,b,e   Iverson, Grant L ^b,c   Feldman, Howard H ^c   Holdnack, James A ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b BC Mental Health & Addiction Services   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d PEARSON   (United States)

^e ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

Alzheimer's disease; Assessment; False positive; Guidelines; Memory; Mild cognitive impairment; Misdiagnosis; Wechsler Memory Scale

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; EDUCATION; FALSE POSITIVE RESULT; FEMALE; HUMAN; INTELLIGENCE; LEARNING; MALE; MEMORY DISORDER; PRIORITY JOURNAL; PROBABILITY; PSYCHOMETRY; RECALL; RECOGNITION; SCORING SYSTEM; WECHSLER MEMORY SCALE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DIAGNOSTIC ERRORS; EDUCATION; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INTELLIGENCE TESTS; LEARNING; MALE; MEMORY; MEMORY DISORDERS; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; REPRODUCIBILITY OF RESULTS;

EID: 65449176873     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000215390     Document Type: Article

References (54)

1. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rosser M, Salloway S, Stern Y, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria - a position paper. Lancet Neurol 2007;6:734-746.
2. Iverson GL, Brooks BL: Improving accuracy for identifying cognitive impairment; in Schoenberg MR, Scott JG (eds): The Black Book of Neuropsychology: A Syndrome-Based Approach. New York, Springer, in press.
3. Heaton RK, Miller SW, Taylor MJ, Grant I: Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults professional manual. Lutz, Psychological Assessment Resources, 2004.
4. Heaton RK, Grant I, Matthews CG: Comprehensive norms for an extended Halstead-Reitan battery: demographic corrections, research findings, and clinical applications. Odessa, Psychological Assessment Resources, 1991.
5. Iverson GL, Brooks BL, White T, Stern RA: Neuropsychological assessment battery (NAB): introduction and advanced interpretation; in Horton AM Jr, Wedding D (eds): The Neuropsychology Handbook. New York, Springer, 2008, pp 279-343.
6. Crawford JR, Garthwaite PH, Gault CB: Estimating the percentage of the population with abnormally low scores (or abnormally large score differences) on standardized neuropsychological test batteries: a generic method with applications. Neuropsychology 2007;21:419-430.
7. Axelrod BN, Wall JR: Expectancy of impaired neuropsychological test scores in a non-clinical sample. Int J Neurosci 2007;117:1591-1602.
8. Schretlen DJ, Testa SM, Winicki JM, Pearlson GD, Gordon B: Frequency and bases of abnormal performance by healthy adults on neuropsychological testing. J Int Neuropsychol Soc 2008;14:436-445.
9. Binder LM, Iverson GL, Brooks BL: To err is human: 'abnormal' neuropsychological scores and variability are common in healthy adults. Arch Clin Neuropsychol 2009;24:31-46.
10. Stern RA, White T: Neuropsychological assessment battery. Lutz, Psychological Assessment Resources, 2003.
11. Horton AM Jr: Above-average intelligence and neuropsychological test score performance. Int J Neurosci 1999;99:221-231.
12. Warner MH, Ernst J, Townes BD, Peel J, Preston M: Relationships between IQ and neuropsychological measures in neuropsychiatric populations: within-laboratory and cross-cultural replications using WAIS and WAIS-R. J Clin Exp Neuropsychol 1987;9:545-562.
13. Tremont G, Hoffman RG, Scott JG, Adams RL: Effect of intellectual level on neuropsychological test performance: a response to Dodrill (1997). Clin Neuropsychol 1998;12:560-567.
14. Steinberg BA, Bieliauskas LA, Smith GE, Ivnik RJ, Malec JF: Mayo's older Americans normative studies: age-and IQ-adjusted norms for the Auditory Verbal Learning Test and the Visual Spatial Learning Test. Clin Neuropsychol 2005;19:464-523.
15. Steinberg BA, Bieliauskas LA, Smith GE, Ivnik RJ: Mayo's older Americans normative studies: age-and IQ-adjusted norms for the Trail-Making Test, the Stroop test, and MAE Controlled Oral Word Association Test. Clin Neuropsychol 2005;19:329-377.
16. Wechsler D: Wechsler Memory Scale, ed. 3 San Antonio, Psychological Corporation, 1997.
17. Wechsler D: Wechsler Adult Intelligence Scale, ed 3. San Antonio, Psychological Corporation, 1997.
18. Blackford RC, LaRue A: Criteria for diagnosing age-associated memory impairment: proposed improvement from the field. Dev Neuropsychol 1989;5:295-306.
19. de Rotrou J, Wenisch E, Chausson C, Dray F, Faucounau V, Rigaud AS: Accidental MCI in healthy subjects: a prospective longitudinal study. Eur J Neurol 2005;12:879-885.
20. Palmer BW, Boone KB, Lesser IM, Wohl MA: Base rates of 'impaired' neuropsychological test performance among healthy older adults. Arch Clin Neuropsychol 1998;13:503-511.
21. Brooks BL, Iverson GL, White T: Substantial risk of 'accidental MCI' in healthy older adults: base rates of low memory scores in neuropsychological assessment. J Int Neuropsychol Soc 2007;13:490-500.
22. Loewenstein DA, Acevedo A, Ownby R, Agron J, Barker WW, Isaacson R, Strauman S, Duara R: Using different memory cutoffs to assess mild cognitive impairment. Am J Geriatr Psychiatry 2006;14:911-919.
23. Brooks BL, Iverson GL, Holdnack JA, Feldman HH: The potential for misclassification of mild cognitive impairment: a study of memory scores on the Wechsler Memory Scale-III in healthy older adults. J Int Neuropsychol Soc 2008;14:463-478.
24. Petersen RC, Smith GE, Ivnik RJ, Kokmen E, Tangalos EG: Memory function in very early Alzheimer's disease. Neurology 1994;44:867-872.
25. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
26. Tulving E, Thompson D: Encoding specificity and retrieval processes in episodic memory. Psychol Rev 1973;80:352-373.
27. Grober E, Buschke H: Genuine memory deficits in dementia. Dev Neuropsychol 1987;3:13-36.
28. Grober E, Kawas C: Learning and retention in preclinical and early Alzheimer's disease. Psychol Aging 1997;12:183-188.
29. The Psychological Corporation: WAIS-III/ WMS-III technical manual. San Antonio, Psychological Corporation, 1997.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
31. Rabin LA, Barr WB, Burton LA: Assessment practices of clinical neuropsychologists in the United States and Canada: a survey of INS, NAN, and APA division 40 members. Arch Clin Neuropsychol 2005;20:33-65.
32. The Psychological Corporation: Wechsler Test of Adult Reading manual. San Antonio, Psychological Corporation, 2001.
33. Strauss E, Sherman EMS, Spreen O: A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, ed 3. New York, Oxford University Press, 2006.
34. Bright P, Jaldow E, Kopelman MD: The national adult reading test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables. J Int Neuropsychol Soc 2002;8:847-854.
35. Maddrey AM, Cullum CM, Weiner MF, Filley CM: Premorbid intelligence estimation and level of dementia in Alzheimer's disease. J Int Neuropsychol Soc 1996;2:551-555.
36. McFarlane J, Welch J, Rodgers J: Severity of Alzheimer's disease and effect on premorbid measures of intelligence. Br J Clin Psychol 2006;45:453-463.
37. O'Carroll RE, Prentice N, Murray C, van Beck M, Ebmeier KP, Goodwin GM: Further evidence that reading ability is not preserved in Alzheimer's disease. Br J Psychiatry 1995;167:659-662.
38. Fromm D, Holland AL, Nebes RD, Oakley MA: A longitudinal study of word-reading ability in Alzheimer's disease: evidence from the national adult reading test. Cortex 1991;27:367-376.
39. Steinberg BA, Bieliauskas LA, Smith GE, Ivnik RJ: Mayo's older Americans normative studies: age-and IQ-adjusted norms for the Wechsler Memory Scale - Revised. Clin Neuropsychol 2005;19:378-463.
40. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ: Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379-2388.
41. Thal LJ, Ferris SH, Kirby L, Block GA, Lines CR, Yuen E, Assaid C, Nessly ML, Norman BA, Baranak CC, Reines SA: A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology 2005;30:1204-1215.
42. Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R: Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 2007;6:501-512.
43. Birks J, Flicker L: Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 2006;3:CD006104.
44. Birks J, Flicker L: Selegiline for Alzheimer's disease. Cochrane Database Syst Rev 2003;1: CD000442.
45. Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, Richardson S: Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 2004;63:651-657.
46. Hutchinson AD, Mathias JL: Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review. J Neurol Neurosurg Psychiatry 2007;78:917-928.
47. Hamilton JM, Salmon DP, Galasko D, Delis DC, Hansen LA, Masliah E, Thomas RG, Thal LJ: A comparison of episodic memory deficits in neuropathologically confirmed dementia with Lewy bodies and Alzheimer's disease. J Int Neuropsychol Soc 2004;10:689-697.
48. O'Donnell BF, Drachman DA, Lew RA, Swearer JM: Measuring dementia: assessment of multiple deficit domains. J Clin Psychol 1988;44:916-923.
49. Griffith HR, Netson KL, Harrell LE, Zamrini EY, Brockington JC, Marson DC: Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period. J Int Neuropsychol Soc 2006;12:166-175.
50. Greenaway MC, Lacritz LH, Binegar D, Weiner MF, Lipton A, Munro Cullum C: Patterns of verbal memory performance in mild cognitive impairment, Alzheimer disease, and normal aging. Cogn Behav Neurol 2006;19:79-84.
51. Delis DC, Wetter SR, Jacobson MW, Peavy G, Hamilton J, Gongvatana A, Kramer JH, Bondi MW, Corey-Bloom J, Salmon DP: Recall discriminability: utility of a new CVLT-II measure in the differential diagnosis of dementia. J Int Neuropsychol Soc 2005;11:708-715.
52. Lacritz LH, Cullum CM, Weiner MF, Rosenberg RN: Comparison of the Hopkins Verbal Learning Test-Revised to the California Verbal Learning Test in Alzheimer's disease. Appl Neuropsychol 2001;8:180-184.
53. Ritchie LJ, Frerichs RJ, Tuokko H: Effective normative samples for the detection of cognitive impairment in older adults. Clin Neuropsychol 2007;21:863-874.
54. Petersen RC, Negash S: Mild cognitive impairment: an overview. CNS Spectr 2008;13:45-53.